Affimed is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Prenigma is providing a self-service solution to drive clinical trials outcome using advanced analytics and artificial intelligence.
Comments